Effect of SCH 23390 on (±)-3,4-methylenedioxymethamphetamine hyperactivity and self-administration in rats

This publication has 55 references indexed in Scilit:

• Effect of acute and chronic administration of the selective 5‐HT_2C receptor antagonist SB‐243213 on midbrain dopamine neurons in the rat: An in vivo extracellular single cell study
  Synapse, 2002
• SR46349-B, a 5-HT2A/2C Receptor Antagonist, Potentiates Haloperidol-induced Dopamine Release in Rat Medial Prefrontal Cortex and Nucleus Accumbens
  Neuropsychopharmacology, 2002
• Role of the endocannabinoid system in MDMA intracerebral self‐administration in rats
  British Journal of Pharmacology, 2002
• Pharmacological Studies of the Acute Effects of (+)-3,4-Methylenedioxymethamphetamine on Locomotor Activity, Role of 5-HT1B/1D and 5-HT2 Receptors
  Neuropsychopharmacology, 2002
• Effects of (+)-fenfluramine on 3,4-methylenedioxymethamphetamine (MDMA) discrimination in rats
  Pharmacology Biochemistry and Behavior, 1996
• MDL72222, a serotonin 5-HT3 receptor antagonist, blocks MDMA's ability to establish a conditioned place preference
  Pharmacology Biochemistry and Behavior, 1991
• Antagonism of cocaine self-administration by selective dopamine D1 and D2 antagonists
  Behavioural Pharmacology, 1990
• Receptor subtype-specific dopaminergic agents and conditioned behavior
  Neuroscience & Biobehavioral Reviews, 1989
• Pharmacologic profile of MDMA (3,4-methylenedioxymethamphetamine) at various brain recognition sites
  European Journal of Pharmacology, 1988
• Self-administration of methylenedioxymethamphetamine (MDMA) by rhesus monkeys
  Drug and Alcohol Dependence, 1986